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Introduction
The discovery of two small RNAs, lin-4
and let-7 during the study of genes
involved in timing of larval development
of Caenohabditis elegans was the official
introduction of the microRNAs (miRNA)
to the world1,2). Only 17 to 23 nucelotides
in length, these small RNAs were soon
recognized as a key regulator of the devel-
opment of C.elegans and interestingly
they were highly conserved across species.
Following the initial discovery, numerous
groups have began their own expedition
onto the unknown territories of the world
of miRNA, and have successfully identi-
fied that not only were they crucial for
the larval development but also in cell
proliferation3) and apoptosis4), immunore-
sponse5), protein expression6) and tissue
development7) as well as in various other
biological processes. Currently, few
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= Abstract =
Over the past decade, microRNA has been emerging as a key regulator involved in various biological and
physiological process including cell cycle, tissue development and pathogenesis. The effort to decipher the
complicated machinery behind microRNA function is underway yet the complete understanding is far from
being reached. However, various groups have made successful identification of the role of a specific microR-
NA involved in a specific process. This article summarizes the microRNAs identified in one such specific area,
namely, differentiation of mesenchymal stem cell. Characterized by its unique potential to differentiate into
three separate tissue cell types, adipocyte, chondrocyte and osteoblast, mesenchymal stem cells have been of
immense interest for its possible applicability in regenerative medicine. Despite this interest, however, the
study of microRNA function in MSCs differentiation remains rudimentary. The aim of this paper is to summa-
rize the currently identified, experimentally validated and accepted by the scientific community as novel,
microRNAs involved in MSC differentiation. 
Key Words: MicroRNA, Mesenchymal stem cell, Differentiation
miRNA are clearly identified and assigned
to specific function in mammals. miR-181
promotes B cell development in mice8), and
it targets the homeobox protein Hox-A11
during mammalian myoblast differentia-
tion9). miR-196 regulates several Hox
genes while the brain-specific miR-134
regulates dendritic spine development10).
miR-1, miR-133 and miR-206 are specifi-
cally induced during myogenesis11) and
miR-143 are known to regulate adiocytic
differentiation12). However, despite the
recent achievements in identification of
miRNAs involved in various processes, the
studies on the miR function in one partic-
ular field of physiology remain at primi-
tive stage: the differentiation of mes-
enchymal stromal cells. 
Mesecnhymal stromal cell, also known as
MSCs, are plastic-adherent, fibroblast-like
cells first identified and described by
Friedenstein13). Following its initial discov-
ery, various groups have identified the
cells capacity to differentiate into multiple
connective tissue cell types, including fat,
tendon, cartilage and bone14,15,16). Their wide
abundance in body coupled with their mul-
tipotent differentiation capacity has made
the MSCs an ideal candidate for use in
regenerative medicine, which led to the
creation of its alias, mesenchymal stem
cell, coined by Caplan. Despite this
immense interest in dissecting the exact
mechanism behind MSCs capacity to differ-
entiate into multiple lineages, our under-
standing of all the regulators involved in
MSC differentiation remains elusive. Until
recently, MSCs differentiation was thought
to be solely regulated by various transcrip-
tion and growth factors, hormones, and
signaling pathways provided in an optimal
condition. However, with the discovery of
miRNA, and considering its comprehensive
impact on other biological processes, the
regulatory role of miRNA on MSC differ-
entiation seems convincing. 
The functional mechanism of
microRNA 
Before attempting to understand the
complex regulatory functions miRNA may
have on the differentiation process of
MSCs, sound knowledge in how miRNA
are synthesized and, more importantly
how they induce inhibitory effect on its
target gene must be established. Current-
ly, 10883 hairpin precursor miRNAs,
expressing 10581 mature miRNA products,
in 115 species have been identified in the
Sanger database version 14.0. Being either
intronic or exonic, and often located in
non-coding regions between genes (inter-
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Fig. 1. Genomic locations of miRNAs. miRNAs may be
located virtually anywhere on the genome. A.
miRNA may be located within the exon of a non-
coding transcript B. miRNAs may be located
within the intron of a coding gene. 
Figure obtained from Jeffrey M. Friedman and
Peter A. Jones, MicroRNAs: critical mediators of
differentiation, development and disease 2009
Swiss MED WKLY 139(33-34):466-472
genic) and sometimes within the coding
region, miRNA expression may be induced
by its own promoter (intergenic) or by
that of its host gene (Fig. 1). The tran-
scription product quickly folds back onto
itself, forming a hairpin structure which
is then cleaved by Drosha within the
nucleus17). Once cleaved, it is exported to
cytoplasm by exportin18), secondary cleav-
age by Dicer before forming a functional
complex called RNA-induced silencing
complex (RISC)19). This complex recognizes
the complementary sequence of its miRNA
on the target genes 3’UTR region, which
does not require a perfect match, and
induce inhibition of gene expression by
either of the two mechanisms: mRNA
cleavage20) or translational repression21).
However, the complete identification of all
regulators involved in miRNA expression
and its functioning pathway remains to be
fully identified and the data presented
here only summarizes the knowledge
established and accepted currently. 
MSC differentiation 
As previously mentioned, MSCs have
trilineage differentiation potential to dif-
ferentiate into adipoblast, chondroblast
and osteoblast resulting in formation of
fat, cartilage and bone, respectively.
Recent advances in transcriptomics and
proteomics have allowed us to study tran-
scriptional regulation involved in these
stage in more detail and have yielded
valuable information. In the following
sections, the differentiation process into
three separate lineages will be examined
closely involving identified transcription
factors, genes and miRNA. 
I. Osteogenesis 
The long and complicated process of
osteogenesis is initiated with cellular pro-
liferation followed by extracellular matu-
ration (ECM) which ultimately leads to
matrix mineralization. Bone morphogenic
protein (BMP), Wnt and Hedgehog signal-
ing are accepted as the key signaling
pathway involved during the process.
These signaling pathways work symbioti-
cally in a systematically regulated path-
way and exert their impact on down-
stream transcription factors such as
Cbfa1/Runx2, Msx2, Dlx5 and Osterix.
Over the past decade, handfuls of miR-
대한정형외과연구학회지 제 12 권 제 2 호 2009년
— 88 —
Table 1. Identified microRNAs involved in osteogenesis and their targets 
microRNA Target Function Reference
miR-133 Runx2/Cbfa1 Negative Zhaoyong Li, 2008
miR-135 SMAD5 Negative Zhaoyong Li, 2008
miR-26a SMAD1 Negative Ettore Luzi et al, 2008
miR-210 AcvR1b Negative Yosuke Mizuno, 2009
miR-141 Distal-less Homeobox5 Negative Tomohiro Itoh, 2009
miR-200a HDAC4, TGFβ3, Negative Tomohiro Itoh, 2009
miR-29b ACVR2A, CTNNB1P1, DUSP1 Postivie Kristina Kapinas, 2009
miR-29 Osteonectin Negative Zhaoyong Li, 2009
List of the published microRNAs targeting genes involved in osteogenesis. Under function column, the microRNAs
shown to inhibit osteogenesis are labeled as “negative” and the microRNAs shown to promote osteogenesis are
labeled “positive.”
NAs have been identified to inhibit or
induce osteogenesis, which are summarized
on Table 1. Specifically, Zhaoyong Li et al.
have identified that miR-133 directly tar-
gets Runx2/Cbfa1 while miR-135 targets
Smad5, which is a key transducer of the
BMP-2 osteogenic signal, both of which
had a complement sequence to respective
miRNAs on their 3’UTR region22). SMAD1
was found to have two binding sites for
miR-26a on its 3’UTR region23) while miR-
210 was identified to promotes osteogenesis
via targeting AcvR1b and that miR-141
and -200a targets Distal-less Homeobox 5,
respectively 24,25). Kristina Kapinas et al.
have discovered that miR-29 suppresses
osteonectin in osteoblast26). Although major-
ity of the data have identified the miRNAs
which had an inhibitory effect on osteogen-
esis, some have also found the miR target-
ing the inhibitors of osteogenesis, which in
turn promoted the differentiation. One
particular study was carried out by Zhaoy-
ong Li, the same group which have suc-
cessfully identified that miR-133 targets
Runx2/Cbfa1, in which they have discov-
ered that miR-29b targets multiple
inhibitors of osteoblast differentiations,
HDAC4, TGFβ3, ACVR2A, CTNNBIP1 and
DUSP227). From these findings, one can
understand that although the basic func-
tioning mechanism of miR is to inhibit the
expression of its target gene by binding to
the 3’UTR region, based on which gene
the miR targets, miR can either promote
or inhibit the differentiation process.
Although the majority of the data men-
tioned in this review have used mouse
osteoblast cell lines, such as MC3T3 and
ST2, and human adipose derive stem cell
(hADSC), the repeating theme here is that
the miRNA is highly conserved across
species and as such the resulting data from
these alternative cell lines are expected to
be readily translated onto MSCs as well. 
II. Chondrogenesis
Similar to osteogenesis, chondrogenesis
also occur via multiple stages initiated by
cell condensation driven by upregulated
N-cadherin, neural cell adhesion moleu-
cule (NCAM) and fibronectin, promoting
cell-to-cell and cell-to-ECM interactions.
Once the differentiating cells become com-
mitted into chondroblast phase, the cells
switch the major components of the ECM
from Type I collagen, which is a charac-
teristic of an undifferentiated MSCs, to
more cartilaginous make up involving
Type-II, Type-IX and Type -XI collagen,
Cartilage oligomeric matrix protein-1
(COMP-1) and Aggrecan. Ultimately, the
chondrocyte reaches the hypertrophic state
where the cells start to express Type-X
collagen, unique to the hypertrophic stage
of chondrogenesis. Eventually, as part of
the natural bone growth and develop-
ment, the hypertrophic chondrocytes
undergo apoptosis and are replaced by
bone. This long and complicated process of
chondrogenesis are directed by number of
signaling pathways involving TGFβ, FGF,
Wnt and Indian hedgehog (Ihh) signaling
to name a few. In turn, the aforemen-
tioned signaling pathways direct the
expression of various transcription factors
involved in chondrogenesis such as the
SOX 5, SOX 6, SOX 9, also known as the
SOX trio. Currently, handful of miRNAs
have been experimentally validated as a
key regulator in chondrogenesis. One
study reported that miRNA18a targets
CCN family protein 2/connective tissue
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growth factor (CCN2/CTGF), which is a
central player in endochondral bone for-
mation28). Additionally, miR-140 was
found to inhibit the expression of histone
deacetylase 429), which may be involved in
long bone development. miR-199a* had a
profound inhibition on the early stages of
chondrogenesis in pluripotent C3H10T1/2
stem cells grown on pellet culture. When
treated with miR-199a*, the authors have
observed significant reduction of key
chondrogenic markers, namely; cartilage
oligomeric matrix protein (COMP), sox 9
and Type II Collagen, whereas inhibition
of miR-199a* resulted in increase of these
genes30). Interestingly, unlike in studies
which focused on the effect of miRNA
during osteogenesis, several groups study-
ing miRNA in chondrogenesis approached
the subject with quite different aspect.
Walter Dunn et al. have examined the
miRNAs expressed on different areas of
articular cartilage, specifically classified
by the degree of weight-bearing. The
authors have found that miRNA-221 and
miR-222 were significantly up-regulated
on higher weight-bearing region identified
as M1, which is located on the anterior
part of the cartilage, suggesting that this
particular localization on anterior medial
condyle may have a certain function on
weight-bearing capacity of the cartilage31).
Another group, have observed that
miRNA-146a were gradually reduced as
osteoarthritis progressed and have also
found out that miR-146a targets matrix
metalloproteinase 13 (MMP-13)32). 
III. Adipogenesis
Similar to the patterns shared by osteo-
genesis and chondrogenesis, adipogenesis
also occur through multiple steps initiated
by commitment to pre-adipocytes. The
signaling cascade is initiated by the co-
expression of CCAAT/enhancer binding
protein β(C/EBPβ) along with C/EBPδ,
which leads to the activation of down-
stream transcription factors C/EBPαand
peroxisome proliferator-activated receptor
γ(PPARγ). By the terminal differentia-
tion stage, numerous genes are expressed
which include hormone-sensitive lipase
(HSL), fatty acid binding protein
(FABPs) and glycerol-3-phosphate dehy-
drogenase (GPDH). During this period,
various adipokines are also secreted
including leptin (LEP) and adiponectin
(ADIPOQ). Michael Karbiener et al. suc-
ceeded in identifying the miRNA target-
ing the key transcription factor during
adipogenesis: PPARγ. By using human
multipotent adipose-derived stem
(hMADS) cells, the authors have found
that when the cells were treated with
miR-27b over-expressing vector, number
of adipogenic marker genes showed
notable decrease in expression, which
included PPARγ, FABP4 and LPL33).
Christine Esau et al. have also observed
the increase of miR-143 in differentiating
adipocytes, and that when miR-143 was
inhibited so was the adipogenesis while BP
Lewis et al. have suggested the possible
target of miR-143 as the extracellular sig-
nal-regulated kinase 5 (ERK5)34). In last
two years, number of groups has also suc-
cessfully identified miRNAs involved in
adipogenesis, including the positive effect
of miR-103 and miR-19-92 cluster had on
adipogenesis35,36) and the negative effect
induced by let-7 and miR-2737,38). In a
study using ST2 cells, J.A. Kennell et al.
have identified multiple miRNAs which
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promoted adipogenesis, which were miR-
200c/141 and miR-200b,a/42939). In
C3H10T1/2 cells, F.Sun et al. have suc-
cessfully identified that miR-24 enhanced
adipogenesis while miR-31 enforced nega-
tive effect40).
Conclusion
Despite being relatively recently identi-
fied, miRNAs are proving to be a critical
mediators in various biological processes
including tissue development, immunore-
sponse, protein expression, viral infection
and cell proliferation, division, apoptosis
and differentiation. However, despite the
recent achievements in identifying the
functioning pathway of miRNA and the
impact of individual miRNA on a specific
pathway, we are still at a primitive stage
in understanding the whole picture that
miRNA draws. One such aspect is our
limited understanding of how miRNA
actually recognizes its target and induce
its effect. Although a computerized algo-
rithm and simplified means of communi-
cations have yielded useful database such
as TargetScan and PicTar, which predicts
the potential target of each identified
miRNA based on sequence complementari-
ty, significant portion of the predicted
targets remained independent of miRNA
treatment. Such result makes us speculate
the existence of additional regulatory
mechanism that exists between the target
mRNAs and the miRNA. Regardless, var-
ious groups are making progress in under-
standing the complete pathway of miRNA
and more importantly, succeeding in
applying miRNA in the field of medicine.
For example, Gilad S et al. have devel-
oped a novel technique to isolate miRNAs
from bodily fluids such as urine41), which
Mitchell et al. have utilized to identify
miR-141 isolated from plasma as a novel
indicator of prostate cancer42). One report
suggested that more than one third of all
protein coding genes in human genome
may be regulated by miRNA43), and con-
sidering the unparalleled advance in tech-
nology as well as the continued global
effort to gain complete understanding of
miRNA, its use and applicability seems,
truly, endless. It seems, paradoxically,
the potential for a molecule with such a
tiny name, microRNA, has an endless
potential.
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